Medical student, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Physician, Occupational Medicine Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Int J Infect Dis. 2021 Dec;113:175-177. doi: 10.1016/j.ijid.2021.10.031. Epub 2021 Oct 21.
Cardiac involvement in COVID-19 can range from mild damage to severe myocarditis. The precise mechanism by which COVID-19 causes myocardial injury is still unknown. Myocarditis following administration of COVID-19 vaccines, especially those based on mRNA, has also been described. However, no reports of heart failure following reinfection with SARS-CoV-2 in patients immunized with an inactivated vaccine have been identified.
The patient was a 47-year-old male construction worker of African descent, with type II diabetes and a history of infection by SARS-CoV-2 in December 2020 and May 2021, confirmed by RT-PCR. He received two doses of an inactivated vaccine against COVID-19. Between the two COVID-19 episodes with positive RT-PCR, he had two episodes of bacterial lung infection. After the second episode of SARS-CoV-2 infection, he was diagnosed with severe heart failure as a sequela of myocarditis.
It is essential to perform a thorough follow-up after infection with SARS-CoV-2 since, even with proper immunization, it is possible that the patient was reinfected and suffered severe cardiac sequelae as a consequence. The hypothesis of an etiology associated with the use of an inactivated vaccine against COVID-19, with a potential immune enhancement mechanism following reinfection with SARS-CoV-2, cannot be rejected.
COVID-19 可导致心脏受累,范围从轻度损伤到严重心肌炎。COVID-19 导致心肌损伤的确切机制仍不清楚。COVID-19 疫苗接种后也有心肌炎的报道,特别是基于 mRNA 的疫苗。然而,尚未发现接种灭活疫苗的患者在再次感染 SARS-CoV-2 后发生心力衰竭的报道。
患者为一名 47 岁的非洲裔男性建筑工人,患有 II 型糖尿病,曾分别于 2020 年 12 月和 2021 年 5 月经 RT-PCR 确诊感染 SARS-CoV-2。他接种了两剂 COVID-19 灭活疫苗。在两次 RT-PCR 阳性的 COVID-19 发作之间,他发生了两次细菌性肺部感染。在第二次 SARS-CoV-2 感染后,他被诊断为心肌炎后遗症引起的严重心力衰竭。
对 SARS-CoV-2 感染进行彻底随访至关重要,因为即使进行了适当的免疫接种,患者仍有可能再次感染并因此导致严重的心脏后遗症。不能排除与 COVID-19 灭活疫苗使用相关的病因假说,以及 SARS-CoV-2 再次感染后的潜在免疫增强机制。